Evaluation of the sensitivity and specificity of immunohistochemical markers in the differential diagnosis of effusion cytology

Oman Medical Journal

Volumn 28, Issue 6, 2013, Pages 410-416

  Yahya, Zahraa Mohammed ^a   Ali, Hussam Hasson ^a   Hussein, Haider Ghazi ^b  

^a Al Nahrain University College of Medicine   (Iraq)

^b UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Adenocarcinoma; Calretinin; Carcinoembryonic antigen; Effusion; Mesothelial Cells

Indexed keywords

CALRETININ; CARCINOEMBRYONIC ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ASCITES FLUID; BENIGN TUMOR; BIOPSY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; EFFUSION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIVER CIRRHOSIS; LUNG EMBOLISM; MALE; MALIGNANT EFFUSION; MESOTHELIUM CELL; NEPHROTIC SYNDROME; PAPANICOLAOU TEST; PARACENTESIS; PNEUMONIA; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THORACOCENTESIS;

EID: 84887371953     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2013.117     Document Type: Article

References (30)

1. Shidham VB, Falzon M. Serous effusions. In: Gray W, Kocjan G: editors. Diagnostic Cytopathology, 3rd Edition. Churchill Livingstone, Elsevier 2010; p 115-175.
2. He DN, Zhu HS, Zhang KH, Jin WJ, Zhu WM, Li N, et al. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions. World J Gastroenterol 2004 Aug;10(16):2406-2408.
3. Butnor KJ. My approach to the diagnosis of mesothelial lesions. J Clin Pathol 2006 Jun;59(6):564-574.
4. Lyons-Boudreaux V, Mody DR, Zhai J, Coffey D. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology? Arch Pathol Lab Med 2008 Jan;132(1):23-28.
5. Murugan P, Siddaraju N, Habeebullah S, Basu D. Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief review of the literature. Indian J Pathol Microbiol 2009 Apr-Jun;52(2):175-181.
6. Davidson B. Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature. Anal Cell Pathol 2001;23(3-4):107-128.
7. Pereira TC, Saad RS, Liu Y, Silverman JF. The diagnosis of malignancy in effusion cytology: a pattern recognition approach. Adv Anat Pathol 2006 Jul;13(4):174-184.
8. Reid PT, Innes JA. Respiratory disease. In: Colledge NR, Walker BR, Ralston SH, editors. Davidson's Principles and Practice of Medicine, 21st Edition. Churchill Livingstone, Elsevier 2010; p 641-730.
9. Collier JD, Webster G. Liver and biliary tract disease. In: Colledge NR, Walker BR, Ralston SH, editors. Davidson's Principles and Practice of Medicine, 21st Edition. Churchill Livingstone, Elsevier 2010; p 919-984.
10. Agarwal C, Jain M. Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions. Indian J Pathol Microbiol 2009 Jan-Mar;52(1):25-28.
11. Kushwaha R, Shashikala P, Hiremath S, Basavaraj HG. Cells in pleural fluid and their value in differential diagnosis. J Cytol 2008;25:138-143.
12. Ozcakar B, Martinez CH, Morice RC, Eapen GA, Ost D, Sarkiss MG, et al. Does pleural fluid appearance really matter? The relationship between fluid appearance and cytology, cell counts, and chemical laboratory measurements in pleural effusions of patients with cancer. J Cardiothorac Surg 2010;5:63.
13. Bibbo M, Wilbur DC, eds. Comprehensive Cytopathology, 3rd ed. Saunders, Elsevier 2008; p514-577.
14. Hanley KZ, Facik MS, Bourne PA, Yang Q, Spaulding BO, Bonfiglio TA, et al. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions. Cancer 2008 Feb;114(1):49-56. Cancer Cytopathol.
15. Saleh HA, El-Fakharany M, Makki H, Kadhim A, Masood S. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis. Diagn Cytopathol 2009 May;37(5):324-332.
16. Su XY, Li GD, Liu HB, Jiang LL. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion]. Ai Zheng 2004 Oct;23(10):1185-1189.
17. Thapar M, Mishra RK, Sharma A, Goyal V, Goyal V. Critical analysis of cell block versus smear examination in effusions. J Cytol 2009 Apr;26(2):60-64.
18. Ali HH, Hammed AW. AL-Okabi ZT. Diagnostic value of CEA and CA19-9 levels in pleural effusions, correlation with cytology. Ir J Med Sci 2003;2(2):67-75.
19. Light RW. Clinical practice. Pleural effusion. N Engl J Med 2002 Jun;346(25):1971-1977.
20. Grefte JM, de Wilde PC, Salet-van de Pol MR, Tomassen M, Raaymakersvan Geloof WL, Bulten J. Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions. Acta Cytol 2008 Jan-Feb;52(1):35-44.
21. Palaoro LA, Rocher AE, Rofrano J, Curi SM, Penzutti V. Utility of AgNOR, Immunocytochemistry for CEA and Tumer Markers for Diagnosis in Serous Fluids. Revista Brasileira de cancerologia 2008; 54:317-323.
22. Nussrat FL, Ali HH, Hussein HG, Al-Ukashi RJ. Immunohistochemical Expression of ki-67 and p53 in Colorectal Adenomas: A Clinicopathological Study. Oman Med J 2011 Jul;26(4):229-234.
23. Qasim BJ, Ali HH, Hussein AG. Immunohistochemical expression of estrogen and progesterone receptors in human colorectal adenoma and carcinoma using specified automated cellular image analysis system: a clinicopathological study. Oman Med J 2011 Sep;26(5):307-314.
24. Chaloob MK, Ali HH, Qasim BJ, Mohammed AS. Immunohistochemical Expression of Ki-67, PCNA and CD34 in Astrocytomas: A Clinicopathological Study. Oman Med J 2012 Sep;27(5):368-374.
25. Sato A, Torii I, Okamura Y, Yamamoto T, Nishigami T, Kataoka TR, et al. Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium. Mod Pathol 2010 Nov;23(11):1458-1466.
26. Fetsch PA, Abati A. Immunocytochemistry in effusion cytology: a contemporary review. Cancer 2001 Oct;93(5):293-308.
27. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindan J. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 2001 Feb;93(1):68-72.
28. Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn Cytopathol 2005 Mar;32(3):151-155.
29. Hongming L, Wang Xiaobin HC, et al. Application of Calretinin, VIM, ENTIN, CEA, EMA in Cytologic Diagnosis of Dropsy of Serous Cavity. Chinese Journal of Clinical Oncology 2001;3:19.
30. Ko EC, Jhala NC, Shultz JJ, Chhieng DC. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology. Am J Clin Pathol 2001 Nov;116(5):709-715.